Amgen Inc. (AMGN)
USD 258.78
(-2.7%)
USD 258.78
(-2.7%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 6.71 Billion USD | 2.52% |
| 2022 | 6.55 Billion USD | 11.18% |
| 2021 | 5.89 Billion USD | -18.87% |
| 2020 | 7.26 Billion USD | -7.37% |
| 2019 | 7.84 Billion USD | -6.58% |
| 2018 | 8.39 Billion USD | 324.15% |
| 2017 | 1.97 Billion USD | -74.37% |
| 2016 | 7.72 Billion USD | 11.28% |
| 2015 | 6.93 Billion USD | 34.53% |
| 2014 | 5.15 Billion USD | 1.52% |
| 2013 | 5.08 Billion USD | 16.94% |
| 2012 | 4.34 Billion USD | 17.97% |
| 2011 | 3.68 Billion USD | -20.4% |
| 2010 | 4.62 Billion USD | 0.48% |
| 2009 | 4.6 Billion USD | 9.75% |
| 2008 | 4.19 Billion USD | 32.53% |
| 2007 | 3.16 Billion USD | 7.32% |
| 2006 | 2.95 Billion USD | -19.71% |
| 2005 | 3.67 Billion USD | 55.48% |
| 2004 | 2.36 Billion USD | 4.58% |
| 2003 | 2.25 Billion USD | 262.33% |
| 2002 | -1.39 Billion USD | -224.31% |
| 2001 | 1.11 Billion USD | -1.65% |
| 2000 | 1.13 Billion USD | 3.84% |
| 1999 | 1.09 Billion USD | 27.02% |
| 1998 | 863.2 Million USD | 33.97% |
| 1997 | 644.3 Million USD | -5.22% |
| 1996 | 679.8 Million USD | 26.43% |
| 1995 | 537.7 Million USD | 68.19% |
| 1994 | 319.7 Million USD | -16.59% |
| 1993 | 383.3 Million USD | 7.19% |
| 1992 | 357.6 Million USD | 265.27% |
| 1991 | 97.9 Million USD | 412.57% |
| 1990 | 19.1 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -113 Million USD | -114.73% |
| 2024 Q2 | 746 Million USD | 760.18% |
| 2024 Q3 | 2.83 Billion USD | 279.36% |
| 2023 Q1 | 2.84 Billion USD | 75.8% |
| 2023 Q4 | 767 Million USD | -55.66% |
| 2023 Q3 | 1.73 Billion USD | 25.45% |
| 2023 Q2 | 1.37 Billion USD | -51.46% |
| 2023 FY | 6.71 Billion USD | 2.52% |
| 2022 Q1 | 1.47 Billion USD | -22.27% |
| 2022 Q2 | 1.31 Billion USD | -10.77% |
| 2022 Q4 | 1.61 Billion USD | -24.59% |
| 2022 FY | 6.55 Billion USD | 11.18% |
| 2022 Q3 | 2.14 Billion USD | 62.72% |
| 2021 Q4 | 1.89 Billion USD | 0.8% |
| 2021 FY | 5.89 Billion USD | -18.87% |
| 2021 Q1 | 1.64 Billion USD | 1.92% |
| 2021 Q2 | 464 Million USD | -71.81% |
| 2021 Q3 | 1.88 Billion USD | 306.03% |
| 2020 Q2 | 1.8 Billion USD | -1.21% |
| 2020 Q3 | 2.02 Billion USD | 12.09% |
| 2020 Q4 | 1.61 Billion USD | -20.09% |
| 2020 Q1 | 1.82 Billion USD | 7.16% |
| 2020 FY | 7.26 Billion USD | -7.37% |
| 2019 Q2 | 2.17 Billion USD | 9.39% |
| 2019 FY | 7.84 Billion USD | -6.58% |
| 2019 Q4 | 1.7 Billion USD | -13.47% |
| 2019 Q3 | 1.96 Billion USD | -9.68% |
| 2019 Q1 | 1.99 Billion USD | 3.32% |
| 2018 Q3 | 1.85 Billion USD | -19.03% |
| 2018 FY | 8.39 Billion USD | 324.15% |
| 2018 Q1 | 2.31 Billion USD | 154.2% |
| 2018 Q4 | 1.92 Billion USD | 3.71% |
| 2018 Q2 | 2.29 Billion USD | -0.65% |
| 2017 Q4 | -4.26 Billion USD | -310.98% |
| 2017 FY | 1.97 Billion USD | -74.37% |
| 2017 Q1 | 2.07 Billion USD | 7.03% |
| 2017 Q2 | 2.15 Billion USD | 3.86% |
| 2017 Q3 | 2.02 Billion USD | -6.04% |
| 2016 Q1 | 1.9 Billion USD | 5.56% |
| 2016 FY | 7.72 Billion USD | 11.28% |
| 2016 Q4 | 1.93 Billion USD | -4.07% |
| 2016 Q3 | 2.01 Billion USD | 7.86% |
| 2016 Q2 | 1.87 Billion USD | -1.58% |
| 2015 Q2 | 1.65 Billion USD | 1.85% |
| 2015 FY | 6.93 Billion USD | 34.53% |
| 2015 Q1 | 1.62 Billion USD | 25.43% |
| 2015 Q3 | 1.86 Billion USD | 12.7% |
| 2015 Q4 | 1.8 Billion USD | -3.38% |
| 2014 Q4 | 1.29 Billion USD | 4.02% |
| 2014 Q1 | 1.07 Billion USD | 5.09% |
| 2014 FY | 5.15 Billion USD | 1.52% |
| 2014 Q3 | 1.24 Billion USD | -19.59% |
| 2014 Q2 | 1.54 Billion USD | 44.18% |
| 2013 FY | 5.08 Billion USD | 16.94% |
| 2013 Q4 | 1.02 Billion USD | -25.37% |
| 2013 Q2 | 1.25 Billion USD | -12.27% |
| 2013 Q1 | 1.43 Billion USD | 81.98% |
| 2013 Q3 | 1.36 Billion USD | 8.74% |
| 2012 Q1 | 1.18 Billion USD | 26.77% |
| 2012 Q3 | 1.1 Billion USD | -12.56% |
| 2012 FY | 4.34 Billion USD | 17.97% |
| 2012 Q4 | 788 Million USD | -28.82% |
| 2012 Q2 | 1.26 Billion USD | 6.93% |
| 2011 Q3 | 454 Million USD | -61.2% |
| 2011 Q4 | 934 Million USD | 105.73% |
| 2011 Q1 | 1.12 Billion USD | 10.08% |
| 2011 FY | 3.68 Billion USD | -20.4% |
| 2011 Q2 | 1.17 Billion USD | 4.0% |
| 2010 Q4 | 1.02 Billion USD | -17.31% |
| 2010 Q2 | 1.2 Billion USD | 3.0% |
| 2010 Q3 | 1.23 Billion USD | 2.83% |
| 2010 FY | 4.62 Billion USD | 0.48% |
| 2010 Q1 | 1.16 Billion USD | 25.35% |
| 2009 Q3 | 1.38 Billion USD | 9.22% |
| 2009 Q1 | 1.01 Billion USD | 6.04% |
| 2009 FY | 4.6 Billion USD | 9.75% |
| 2009 Q2 | 1.26 Billion USD | 24.53% |
| 2009 Q4 | 931 Million USD | -32.83% |
| 2008 FY | 4.19 Billion USD | 32.53% |
| 2008 Q3 | 1.15 Billion USD | 23.06% |
| 2008 Q4 | 961 Million USD | -17.01% |
| 2008 Q1 | 1.13 Billion USD | 36.05% |
| 2008 Q2 | 941 Million USD | -17.17% |
| 2007 FY | 3.16 Billion USD | 7.32% |
| 2007 Q1 | 1.11 Billion USD | 33.37% |
| 2007 Q2 | 1.01 Billion USD | -8.28% |
| 2007 Q4 | 835 Million USD | 315.42% |
| 2007 Q3 | 201 Million USD | -80.27% |
| 2006 Q3 | 1.1 Billion USD | 7771.43% |
| 2006 Q1 | 1 Billion USD | 21.48% |
| 2006 FY | 2.95 Billion USD | -19.71% |
| 2006 Q4 | 833 Million USD | -24.41% |
| 2006 Q2 | 14 Million USD | -98.6% |
| 2005 FY | 3.67 Billion USD | 55.48% |
| 2005 Q3 | 967 Million USD | -6.03% |
| 2005 Q2 | 1.02 Billion USD | 20.49% |
| 2005 Q1 | 854 Million USD | 23.95% |
| 2005 Q4 | 824 Million USD | -14.79% |
| 2004 Q2 | 748.1 Million USD | 8.39% |
| 2004 Q4 | 689 Million USD | 191.95% |
| 2004 FY | 2.36 Billion USD | 4.58% |
| 2004 Q3 | 236 Million USD | -68.45% |
| 2004 Q1 | 690.2 Million USD | 26.2% |
| 2003 Q2 | 607.2 Million USD | 23.09% |
| 2003 Q4 | 546.9 Million USD | -10.65% |
| 2003 Q1 | 493.3 Million USD | 8.09% |
| 2003 Q3 | 612.1 Million USD | 0.81% |
| 2003 FY | 2.25 Billion USD | 262.33% |
| 2002 Q1 | 340.9 Million USD | 109.14% |
| 2002 Q4 | 456.4 Million USD | 117.54% |
| 2002 FY | -1.39 Billion USD | -224.31% |
| 2002 Q3 | -2.6 Billion USD | -730.84% |
| 2002 Q2 | 412.4 Million USD | 20.97% |
| 2001 Q3 | 329.9 Million USD | 2.49% |
| 2001 Q4 | 163 Million USD | -50.59% |
| 2001 Q2 | 321.9 Million USD | 5.58% |
| 2001 FY | 1.11 Billion USD | -1.65% |
| 2001 Q1 | 304.9 Million USD | 44.64% |
| 2000 Q4 | 210.8 Million USD | -41.26% |
| 2000 FY | 1.13 Billion USD | 3.84% |
| 2000 Q3 | 358.9 Million USD | 18.61% |
| 2000 Q2 | 302.6 Million USD | 13.67% |
| 2000 Q1 | 266.2 Million USD | -5.47% |
| 1999 Q1 | 247.2 Million USD | 3.6% |
| 1999 Q3 | 300 Million USD | 12.11% |
| 1999 FY | 1.09 Billion USD | 27.02% |
| 1999 Q4 | 281.6 Million USD | -6.13% |
| 1999 Q2 | 267.6 Million USD | 8.25% |
| 1998 Q3 | 221 Million USD | 2.17% |
| 1998 FY | 863.2 Million USD | 33.97% |
| 1998 Q4 | 238.6 Million USD | 7.96% |
| 1998 Q1 | 187.3 Million USD | 4.23% |
| 1998 Q2 | 216.3 Million USD | 15.48% |
| 1997 Q4 | 179.7 Million USD | 114.44% |
| 1997 Q3 | 83.8 Million USD | -58.2% |
| 1997 Q2 | 200.5 Million USD | 11.2% |
| 1997 Q1 | 180.3 Million USD | 1.29% |
| 1997 FY | 644.3 Million USD | -5.22% |
| 1996 Q2 | 178.7 Million USD | 24.44% |
| 1996 Q4 | 178 Million USD | -0.84% |
| 1996 FY | 679.8 Million USD | 26.43% |
| 1996 Q1 | 143.6 Million USD | -1.37% |
| 1996 Q3 | 179.5 Million USD | 0.45% |
| 1995 Q4 | 145.6 Million USD | -0.14% |
| 1995 FY | 537.7 Million USD | 68.19% |
| 1995 Q2 | 137.7 Million USD | 26.8% |
| 1995 Q1 | 108.6 Million USD | 2162.5% |
| 1995 Q3 | 145.8 Million USD | 5.88% |
| 1994 Q1 | 93.5 Million USD | 2.63% |
| 1994 FY | 319.7 Million USD | -16.59% |
| 1994 Q4 | 4.8 Million USD | -95.79% |
| 1994 Q3 | 114 Million USD | 6.05% |
| 1994 Q2 | 107.5 Million USD | 14.97% |
| 1993 Q2 | 100.2 Million USD | 12.21% |
| 1993 Q3 | 102.7 Million USD | 2.5% |
| 1993 Q4 | 91.1 Million USD | -11.3% |
| 1993 FY | 383.3 Million USD | 7.19% |
| 1993 Q1 | 89.3 Million USD | -33.26% |
| 1992 Q3 | 88.9 Million USD | 24.16% |
| 1992 Q4 | 133.8 Million USD | 50.51% |
| 1992 Q1 | 63.2 Million USD | 5.33% |
| 1992 FY | 357.6 Million USD | 265.27% |
| 1992 Q2 | 71.6 Million USD | 13.29% |
| 1991 Q1 | 36.8 Million USD | 231.43% |
| 1991 Q3 | 49.4 Million USD | 202.07% |
| 1991 Q4 | 60 Million USD | 21.46% |
| 1991 FY | 97.9 Million USD | 412.57% |
| 1991 Q2 | -48.4 Million USD | -231.52% |
| 1990 FY | 19.1 Million USD | 0.0% |
| 1990 Q1 | 6.4 Million USD | -20.0% |
| 1990 Q2 | 11.1 Million USD | 73.44% |
| 1990 Q4 | -28 Million USD | -295.8% |
| 1990 Q3 | 14.3 Million USD | 28.83% |
| 1989 Q2 | 800 Thousand USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q4 | 8 Million USD | 105.13% |
| 1989 Q3 | 3.9 Million USD | 387.5% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AstraZeneca PLC | 5.95 Billion USD | -12.796% |
| Biogen Inc. | 1.16 Billion USD | -478.503% |
| Gilead Sciences, Inc. | 5.66 Billion USD | -18.57% |
| MIRA Pharmaceuticals, Inc. | -11.98 Million USD | 56157.484% |
| Scilex Holding Company | -114.33 Million USD | 5975.047% |
| Scilex Holding Company | -114.33 Million USD | 5975.047% |